SEC Filing Summary: Park Ha Biological Technology Co., Ltd.
Business Context and Reporting Period
This Form 6-K filing by Park Ha Biological Technology Co., Ltd., a Cayman Islands company, covers the month of November 2025. The report serves to furnish documents related to the Company's 2025 Extraordinary General Meeting. The Company's principal executive office is located in Wuxi, Jiangsu Province, People's Republic of China.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the convening of an Extraordinary General Meeting.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It includes the following exhibits:
- Exhibit 99.1: Notice of 2025 Extraordinary General Meeting dated November 28, 2025.
- Exhibit 99.2: Form of Proxy Card for shareholders.
Key Facts for Investor Verification
- Verify the specific agenda items and resolutions to be voted on at the 2025 Extraordinary General Meeting, as they are not detailed in this summary.
- Confirm the record date and deadline for proxy submissions referenced in the attached Notice and Proxy Card.
- Note that this filing contains no financial data; investors should refer to the most recent Form 20-F or quarterly reports for financial performance.